Stratos Investment Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.95M Buy
37,686
+2,922
+8% +$236K 0.11% 118
2026
Q1
$3.01M Buy
34,764
+130
+0.4% +$12.5K 0.12% 110
2025
Q4
$3.33M Buy
34,634
+376
+1% +$36.5K 0.13% 103
2025
Q3
$3.26M Buy
34,258
+1,261
+4% +$116K 0.13% 101
2025
Q2
$2.88M Buy
32,997
+317
+1% +$26.9K 0.13% 111
2025
Q1
$2.94M Buy
32,680
+3,776
+13% +$338K 0.16% 100
2024
Q4
$2.31M Sell
28,904
-2,267
-7% -$196K 0.14% 94
2024
Q3
$2.81M Sell
31,171
-16,986
-35% -$1.43M 0.2% 87
2024
Q2
$3.79M Buy
48,157
+4,978
+12% +$408K 0.31% 81
2024
Q1
$3.76M Buy
43,179
+4,875
+13% +$416K 0.37% 72
2023
Q4
$3.16M Buy
38,304
+2,446
+7% +$186K 0.37% 66
2023
Q3
$2.81M Buy
35,858
+2,405
+7% +$201K 0.42% 65
2023
Q2
$2.95M Buy
33,453
+578
+2% +$49.8K 0.45% 57
2023
Q1
$2.65M Buy
32,875
+2,486
+8% +$203K 0.45% 58
2022
Q4
$2.36M Buy
30,389
+2,307
+8% +$187K 0.42% 62
2022
Q3
$2.27M Sell
28,082
-1,418
-5% -$127K 0.46% 59
2022
Q2
$2.65M Buy
29,500
+664
+2% +$67.3K 0.5% 56
2022
Q1
$3.2M Buy
28,836
+737
+3% +$77.9K 0.53% 57
2021
Q4
$2.91M Buy
28,099
+749
+3% +$86.7K 0.46% 60
2021
Q3
$3.43M Buy
27,350
+5,875
+27% +$760K 0.6% 50
2021
Q2
$2.67M Buy
21,475
+1,255
+6% +$158K 0.73% 47
2021
Q1
$2.39M Sell
20,220
-1,387
-6% -$163K 0.76% 44
2020
Q4
$2.53M Buy
21,607
+1,723
+9% +$190K 0.8% 41
2020
Q3
$2.07M Buy
19,884
+429
+2% +$43.1K 0.75% 41
2020
Q2
$1.78M Buy
19,455
+2,887
+17% +$277K 0.75% 42
2020
Q1
$1.49M Buy
16,568
+1,064
+7% +$113K 0.8% 41
2019
Q4
$1.76M Buy
15,504
+1,067
+7% +$117K 0.82% 36
2019
Q3
$1.57M Buy
14,437
+1,552
+12% +$162K 0.89% 31
2019
Q2
$1.25M Buy
12,885
+1,429
+12% +$130K 0.79% 34
2019
Q1
$1.04M Buy
+11,456
New +$1.03M 0.82% 33

Other funds holding MDT

Stratos Investment Management's MDT Position: Q2 2026 in Review

Stratos Investment Management increased its Medtronic (MDT) stake by 8.4% in Q2 2026, buying an estimated $236K and bringing the position to 37,686 shares worth $2.95M. The position accounts for 0.11% of the portfolio, ranked #118.

Stratos Investment Management first reported a position in MDT in Q1 2019 and has held it in 30 quarters since. The position peaked at $3.79M in Q2 2024. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Stratos Investment Management held 37,686 shares of Medtronic worth $2.95M as of Q2 2026.
  • Stratos Investment Management bought 2,922 Medtronic shares in Q2 2026, an estimated $236K.
  • Medtronic made up 0.11% of Stratos Investment Management's portfolio in Q2 2026, its #118 holding.
  • Stratos Investment Management first reported a position in Medtronic in Q1 2019 and has held it in 30 quarters since.
  • Stratos Investment Management's Medtronic position peaked at $3.79M in Q2 2024.
  • 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Stratos Investment Management's 13F filing for Q2 2026, filed 11 Aug 2026.